The Use of Antidepressants for Headache Prophylaxis

CNS Neuroscience and Therapeutics

Volumn 17, Issue 5, 2011, Pages 462-469

  Smitherman, Todd A ^a   Walters, A Brooke ^a   Maizels, Morris ^b   Penzien, Donald B ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b Blue Ridge Headache Center   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Antidepressants; Migraine; Pharmacotherapy; Preventive medication; Tension type headache

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIPTAN DERIVATIVE; VENLAFAXINE;

ANXIETY; BEDTIME DOSAGE; CHRONIC TENSION HEADACHE; COMORBIDITY; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; HEADACHE; HUMAN; INSOMNIA; MIGRAINE; NEUROMODULATION; PATHOPHYSIOLOGY; PRESCRIPTION; REVIEW; SEROTONIN SYNDROME; STRESS MANAGEMENT; TREATMENT OUTCOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR THERAPY; CHRONIC DISEASE; HEADACHE; HUMANS; MIGRAINE DISORDERS; TENSION-TYPE HEADACHE; TREATMENT OUTCOME;

EID: 80053195104     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00170.x     Document Type: Review

References (60)

1. Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA 2004;291:493-494.
2. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 1998;279:381-383.
3. Stovner LJ, Tronvik E, Hagen K. New drugs for migraine. J Headache Pain 2009;10:395-406.
4. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability. J Affect Disord 2000;58:19-36.
5. Hirschfield RM. Efficacy of SSRIs and newer antidepressants in severe depression. J Clin Psychiatry 1999;60:326-335.
6. Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME. Comprehensive analysis of remissions (COMPARE) with venlafaxine versus SSRIs. Biol Psychiatry 2008;63:424-434.
7. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Hollan PR. Neurobiology of migraine. Neuroscience 2009;161:327-341.
8. Baskin SM, Lipchik GL, Smitherman TA. Mood and anxiety disorders in chronic headache. Headache 2006;46(Suppl 3):S76-S87.
9. Hamel E. Serotonin and migraine: Biology and clinical implications. Cephalalgia 2007;27:1295-1300.
10. Couch JR, Hassanein RS. Migraine and depression: Effect of amitriptyline prophylaxis. Trans Am Neurol Assoc 1976;101:234-237.
11. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979;36:695-699.
12. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 1973;36:684-690.
13. Ziegler DK, Hurwitz A, Hassanein, RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis: A comparison of propranolol and amitriptyline. Arch Neurol 1987;44:486-489.
14. Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in prophylaxis of migraine: Pharmacokinetic and therapeutic effects. Arch Neurol 1993;50:825-830.
15. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry 1996;61:285-290.
16. Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T. Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenic implications. Headache 1996;38:453-457.
17. Diamond S, Baltes BJ. Chronic tension headache treated with amitriptyline: A double-blind study. Headache 1971;11:110-116.
18. Gobel H, Hamouz V, Hansen C, et al. Chronic tension-type headache: Amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994;59:241-249.
19. Pfaffenrath V, Diener HC, Isler H, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: A multi-centre controlled study. Headache 1994;14:149-155.
20. McCrory DC, Penzien DB, Hasselblad V, Gray RN. Evidence report: Behavioral and physical treatments for tension-type and cervicogenic headache. Des Moines, IA: Foundation for Chiropractic Education and Research, 2001. Product No.: 2085.
21. Ahuja GK, Verma AK. Propanolol in prophylaxis of migraine. Indian J Med Res 1985;82:263-265.
22. Bonuso S, Di Stasio E, Barone P, Steardo L. Time-released dihydroergotamine in the prophylaxis of mixed headache: A study versus amitriptyline. Cephalalgia 1983;3(Suppl 1):175-178.
23. Mathew NT. Prophylaxis of migraine and mixed headache: A randomized controlled study. Headache 1981;21:105-109.
24. Moja L, Cusi C, Sterzi R, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD002919. DOI:.
25. Rampello L, Alvano A, Chiechio S, et al. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache. Neuropsychobiology 2004;50:322-328.
26. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-762.
27. Cohen GL. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache 1997;37:433-436.
28. Morland TJ, Storli OV, Mogstad TE. Doxepin in the prophylactic treatment of mixed "vascular" and tension headache. Headache 1979;19:382-383.
29. Elser JM, Woody RC. Migraine headache in the infant and young-child. Headache 1990;30:366-368.
30. Langohr HD, Gerber WD, Koletzki E, Mayer K, Schroth G. Clomipramine and metoprolol in migraine prophylaxis: A double-blind crossover study. Headache 1985;25:107-113.
31. Noone JF. Clomipramine in the prevention of migraine. J Int Med Res 1980;8(Suppl 3):49-52.
32. Silberstein SD, Freitag FG, Bigal ME. Migraine treatment. In: Silberstein S, Lipton RB, Dodick DW, editors. Wolff's headache and other head pain, 8th ed. New York Oxford University Press, 2008;177-292.
33. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headaches with antidepressants: A meta-analysis. Am J Med 2001;111:54-63.
34. Colombo B, Annovazzi POL, Comi G. Therapy of primary headaches: The role of antidepressants. Neurol Sci 2004;25(Suppl 3):S171-S175.
35. Koch HJ, Jürgens TP. Antidepressants in long-term migraine prevention. Drugs 2009;69:1-19.
36. Punay NC, Couch JR. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003;7:51-54.
37. Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci 2006;27:410-415.
38. Bulut S, Berilgen MS, Baran A, Tekatas A, Atmaca M, Mungen B. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: Randomized, double-blind, crossover study. Clin Neurol Neurosurg 2004;107:44-48.
39. Ozyalcin SN, Talu GK, Kiziltan E, Yucel B, Ertas M, Disci R. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005;45:144-152.
40. Zissis NP, Harmoussi S, Vlaikidis N, et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 2007;27:315-324.
41. Taylor AP, Adelman JU, Freeman MC. Efficacy of duloxetine as a migraine preventive medication: Possible predictors of response in a retrospective chart review. Headache 2007;47:1200-1203.
42. Volpe FM. An 8-week, open label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry 2008;69:1449-1454.
43. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004;62:1706-1711.
44. Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin syndrome. Ann Pharmacother 1998;32:33-38.
45. Shapiro RE, Tepper SJ. The serotonin syndrome, triptans, and the potential for drug- drug interactions. Headache 2007;47:266-269.
46. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: Behavioral and physical treatments.1999. Prepared for the US Headache Consortium. Available from: [Accessed 17 December 2009].
47. Holroyd KA, Penzien DB, Rains JC, Lipchik GL, Buse DC. Behavioral management of headache. In: Silberstein SD, Lipton RB, Dodick DW, editors. Wolff's headache and other head pain, 8th ed. New York Oxford University Press, 2008;721-746.
48. Holroyd KA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: A randomized controlled trial. JAMA 2001;285:2208-2215.
49. Breslau N. Psychiatric comorbidity in migraine. Cephalalgia 1998;18(Suppl 22):S56-S61.
50. Heckman BD, Holroyd KA. Tension-type headache and psychiatric comorbidity. Curr Pain Headache Rep 2006;10:439-447.
51. Pompili M, Di Cosimo D, Innamorati M, Lester D, Tatarelli R, Martelletti P. Psychiatric comorbidity in patients with chronic daily headache and migraine: A selective overview including personality traits and suicide risk. J Headache Pain 2009;10:283-290.
52. Saunders K, Merikangas K, Low NCP, Von Korff M, Kessler RC. Impact of comorbidity on headache-related disability. Neurology 2008;70:534-547.
53. Smitherman TA, Rains JC, Penzien DB. Psychiatric comorbidities and migraine chronification. Curr Pain Headache Rep 2009;13:326-331.
54. Keskinbora K, Aydinli I. A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for prevention of migraine. Clin Neurol Neurosurg 2008;100:979-984.
55. Walker Z, Walker RW, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: A comparison between fluoxetine and desipramine. Headache 1998;38:523-528.
56. Holroyd KA, Labus JS, Carlson B. Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: The role of disorder severity and psychiatric comorbidity. Pain 2009;143:213-222.
57. Maizels M, Smitherman TA, Penzien DB. A review of screening tools for psychiatric comorbidity in headache patients. Headache 2006;46(Suppl 3):98-109.
58. Headache Classification Committee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160.
59. Bendtsen L, Bigal ME, Cerbo R, et al. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in tension-type headache: Second edition. Cephalalgia 2009 [Epub ahead of print.
60. Silberstein S, Tfelt-Hansen P, Dodick DW, et al. Task Force of the International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia 2008;28:484-95. Erratum in: Cephalalgia 2008;28:679.